PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

被引：0

作者：

Flora M. Hammond

David N. Alexander

Andrew J. Cutler

Stephen D’Amico

Rachelle S. Doody

William Sauve

Richard D. Zorowitz

Charles S. Davis

Paul Shin

Fred Ledon

Charles Yonan

Andrea E. Formella

Joao Siffert

机构：

[1] Indiana University School of Medicine,Physical Medicine and Rehabilitation

[2] Rehabilitation Hospital of Indiana,undefined

[3] University of California,undefined

[4] Florida Clinical Research Center,undefined

[5] LLC,undefined

[6] Cornerstone Medical Group,undefined

[7] Baylor College of Medicine,undefined

[8] TMS NeuroHealth Centers,undefined

[9] MedStar National Rehabilitation Network,undefined

[10] CSD Biostatistics,undefined

[11] Inc.,undefined

[12] Avanir Pharmaceuticals,undefined

[13] Inc.,undefined

来源：

BMC Neurology | / 16卷

关键词：

Dextromethorphan; Quinidine; Pseudobulbar affect; Dementia; Brain injuries; Stroke; Neuropsychiatric symptoms; Center for neurologic study-lability scale;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 8 条

[1] PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
Hammond, Flora M.
Alexander, David N.
Cutler, Andrew J.
D'Amico, Stephen
Doody, Rachelle S.
Sauve, William
Zorowitz, Richard D.
Davis, Charles S.
Shin, Paul
Ledon, Fred
Yonan, Charles
Formella, Andrea E.
Siffert, Joao
BMC NEUROLOGY, 2016, 16
[2] An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results
Doody, Rachelle S.
D'Amico, Stephen
Cutler, Andrew J.
Davis, Charles S.
Shin, Paul
Ledon, Fred
Yonan, Charles
Siffert, Joao
CNS SPECTRUMS, 2016, 21 (06) : 450 - 459
[3] PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-label Study
Hammond, Flora
Siffert, Joao
Alexander, David
Cutler, Andrew J.
D'Amico, Stephen
Doody, Rachelle
Formella, Andrea
Ledon, Fred
Sauve, William
Shin, Paul
Yonan, Charles
Zorowitz, Richard
NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S365 - S366
[4] SAFETY, TOLERABILITY, AND EFFECTIVENESS OF DEXTROMETHORPHAN/QUINIDINE FOR PSEUDOBULBAR AFFECT IN TRAUMATIC BRAIN INJURY: PRISM-II
Hammond, Flora
Sauve, William
Shin, Paul
Ledon, Fred
Davis, Charles
Yonan, Charles
Siffert, Joao
JOURNAL OF NEUROTRAUMA, 2015, 32 (12) : A19 - A19
[5] Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study
Hammond, Flora M.
Sauve, William
Ledon, Fred
Davis, Charles
Formella, Andrea E.
PM&R, 2018, 10 (10) : 993 - 1003
[6] An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
Pattee, Gary L.
Wymer, James P.
Lomen-Hoerth, Catherine
Appel, Stanley H.
Formella, Andrea E.
Pope, Laura E.
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2255 - 2265
[7] Open-label study of donepezil in traumatic brain injury
Masanic, CA
Bayley, MT
vanReekum, R
Simard, M
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2001, 82 (07): : 896 - 901
[8] Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-label, dose-escalation study
Thisted, Ronald A.
Klaff, Leslie
Schwartz, Sherwyn L.
Wymer, James P.
Culligan, Neil W.
Gerard, Gary
Pope, Laura E.
Berg, James E.
CLINICAL THERAPEUTICS, 2006, 28 (10) : 1607 - 1618

← 1 →